CRI's Comprehensive Analysis of clinical immune-oncology
Cancer Research Institute publishes analysis in Annals of Oncology 2017
"Advances in immuno-oncology (IO) are revolutionizing the standard of care for many types of cancer."
"26 immunotherapies have been approved, and 17 types of cancer have at least one approved im- munotherapy as a treatment option."
"It is probably the best time for progress in oncology in the past decades."